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Introduction: Impaired preoperative kidney function is associated with an increase in post-procedural
major complications and mortality in older elective surgical population. However, little is known about
the impact of poor kidney function on outcomes in emergency surgical setting in this age group. This
study aimed to quantify the effect of impaired kidney function on 30 and 90 days mortality; and
readmission within 30 days following an acute surgical admission in older patients.
Material and methods: The Older Persons Surgical Outcomes Collaboration 2015 cohort study, in four UK
centres and one in Belgium, examined the above relationships. A logistic regression model was used to
assess the odds of outcomes when comparing impaired eGFR to normal eGFR. A total of 402 patients
were included with a mean age of 76.2 years (range 65–103 years), of which 209 (52%) were male.
Results: The prevalence of eGFR <60 ml/min/1.73 m2 was 34.1% (N = 137). Patients with an eGFR of
<60 ml/min/1.73 m2 on admission were more likely to die at 30 and 90 days when compared to patients
with eGFRs 60 ml/min/1.73 m2; respective adjusted OR = 2.98 (95%CI 1.38–6.43, P = 0.006) and 3.37
(95%CI 1.82–6.27, P < 0.001). No differences were observed for 30-day readmission to hospital.
Conclusions: Admission eGFR provides prognostic information which is useful to clinicians in an acute
surgical setting. Whether closer monitoring and focused management at improving kidney function
improves outcome in this patient population warrants further investigation.
C 2017 Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The prevalence of Chronic Kidney Disease (CKD) stages 3–5 in
the UK is reported to be between 5.8% [1] and 8.5% [2], with the
prevalence increasing with age [1–3]. Estimates of over 40% have
commonly been described in Europe and the United States, in
community dwelling older people aged over 80 years [4,5]. Patients
with CKD have been found to have a poor self-awareness of their* Corresponding author at: Division of Population Medicine, Cardiff University,
5th Floor Neuadd Meirionnydd, Heath Park, Cardiff, United Kingdom. Tel.: +44
02920 71698.
E-mail address: hewittj2@cardiff.ac.uk (J. Hewitt).
1 Presently with the University Hospital of Wales, Heath Park, Cardiff CF14 4XW,
Wales, United Kingdom.
2 Presently with Kings College London, Strand, London WC2R 2LS, United
Kingdom.
http://dx.doi.org/10.1016/j.eurger.2017.03.001
1878-7649/C 2017 Published by Elsevier Masson SAS. This is an open access article unddisease and its implications [6] and recognition amongst medical
professionals has been found to be deﬁcient [7,8].
Impaired kidney function is associated with a high hospital
admission rate and subsequently higher risk of adverse outcomes
after medical interventions [9,10] and surgical interventions
[8,11,12].
There are few studies assessing the effect of eGFR in the general
surgical setting and none have been conducted in an elderly
emergency general surgical setting. In 2008, a systematic review
on CKD and short term postoperative mortality found that patients
with CKD undergoing elective non-cardiac surgery, which encom-
passed general surgical and vascular procedures, demonstrated a
two to ﬁve fold higher risk of mortality or cardiovascular events
compared to those with normal renal function [13]. Early stages of
CKD were found to have a detrimental effect on survival and
morbidity. For example, a general and vascular surgical population,
with a mean age of 58 years and CKD stage 3, death within 30 dayser the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tions 1.2 times higher, when compared to normal renal function [8].
To date, little is known about the impact of impaired eGFR on
outcomes in the emergency surgical setting in older patients. The
objective of this international prospective study was to consider
the relationship between renal impairment on a range of clinically
signiﬁcant outcomes in an elderly emergency general surgical
population.
2. Methods
2.1. Study population and data sources
Data collection was performed in 4 UK hospitals (University
Hospital of Wales; Royal Alexandra Hospital Paisley; Aberdeen
Royal Inﬁrmary; Central Manchester Foundation Trust) and one
Belgian Hospital (Ghent University Hospital). All hospitals are part
of the Older Persons Surgical Outcomes Collaboration [www.
opsoc.eu].
Data were collected prospectively using hospital electronic
records or physical records and stored securely with patient
identiﬁable data removed. The relevant institutional approvals
were acquired in all participating centres.
Inclusion criteria were:
 all patients aged 65 years or older;
 unplanned admission to a general surgery ward.
There were no exclusion criteria and all acute surgical
emergency admissions were consecutively included during the
study period.
Baseline demographic data were collected on participating
patients; haemoglobin (<130 g/L classiﬁed as anaemia); albumin
(35 g/L classiﬁed as low), number of medications (grouped as
either being <5 or 5 medications); diabetic history; multi-
morbidity (deﬁned using 20 pre-speciﬁed conditions) [14] and
categorised as 2 or 3 or more; and whether the patient had
surgery or not.
2.2. Outcomes
The primary outcome of interest was Day 90 mortality, and
secondary outcomes were mortality at Day 30 and admission to
hospital within 30 days of discharge.
2.3. Categorising renal function
Patient’s eGFR were acquired in one of two ways; manually
calculated using an online calculator; found here http://egfrcalc.
renal.org/, which uses the modiﬁcation for diet in renal disease
equation and required the input of the patient’s admission
creatinine, age, sex and race. The other method involved recording
the eGFR value automatically calculated from an admission blood
electrolyte test.
For the purpose of this study, eGFR was categorised into the
CKD stages according to the guidelines set out by the National
Kidney Foundation (NKF) [3]. CKD stages 1 and 2 require evidence
of kidney damage to differentiate correctly, data which were not
routinely available on the hospital electronic systems. All eGFR records
that were 60 ml/min/1.73 m2, were categorised as CKD stage 1–2.
The remaining stages were deﬁned along the criteria of the NKF.
2.4. Statistical analysis
A descriptive analysis of the patient demographic and clinical
data on admission was performed on the primary outcome(mortality at Day 90). Primary and secondary outcomes were
analysed using a multivariable logistic regression base model to
determine the effect of eGFR, adjusted for clinically important
covariates of albumin and age group. Subsequently, a forward
stepping multivariable logistic model ﬁtting approach using a
likelihood ratio test of clinical covariates after adjustment of the
base model (age group, albumin and eGFR) was performed. As an
exploratory analysis, comparison of the effects of eGFR partitioned
into the established kidney function categories, against the binary
partition of greater than, versus less than 60, was carried out. All
adjusted odds ratios (ORs) were reported with their associated 95%
conﬁdence internal (95% CI) and P-values. Statistical analysis was
carried out using Stata version 13.0.
3. Results
A total of 402 patients admitted as an acute surgical emergency
in ﬁve participating centres were included in the study and their
baseline characteristics summarised in Table 1. Mean age was
76.2 years (range 65–103 years), with 209 (52%) being male. A total
of 65.9% and 34.1% of patients were classiﬁed as having normal
renal function (eGFR  60 ml/min/1.73 m2) or impaired renal
function (eGFR < 60 ml/min/1.73 m2) respectively.
Missing data for albumin, poly-pharmacy, length of stay and
diabetic status, which individually were missing in <3% of
participants, which were considered to be missing at random.
Table 1 also summarises the outcomes of patients presenting as
acute surgical emergency. In total, there were 22 and 40 deaths
within 30 and 90 days of presentation respectively, and
95 readmissions within 30 days of discharge.
The proportion of patients who died within 90 days of ﬁrst
presentation at hospital was signiﬁcantly greater in patients with
renal impairment (16.1%), when compared to patients with normal
eGFR (6.8%, P < 0.01). A similar trend was seen with 30 day
mortality, with 9.5% of renal impaired patients experiencing the
outcome when compared to non-renal impaired patients (3.4%,
P = 0.01). No difference in readmission between those with renal
impairment (24.8%) and patients with normal renal function (23%,
P = 0.48).
Multivariable analyses showing predictors of 90 day mortality;
30 day mortality and Readmission within 30 days of discharge are
shown in Tables 2 and 3. Table 3 shows a summary of additional
covariates, which were adjusted for age group, albumin and eGFR.
3.1. Outcome 1: mortality within 90 days
After adjustment of age group and albumin; the odds of
mortality at 90 days was higher in patients with an admission eGFR
of <60 ml/min/1.73 m2 (OR = 3.37, 95%CI 1.82–6.27, P  0.001)
when compared to patients with normal eGFR.
Stratifying admission eGFR into the CKD classiﬁcation, mortali-
ty was again higher and worsened with decreasing eGFR when
compared to normal eGFR. The following adjusted ORs were
demonstrated in the corresponding CKD classiﬁcations; CKD 3a
(OR = 2.99, 95%CI 1.36–6.57, P = 0.006), CKD 3b (OR = 3.24, 95%CI
1.31–8.05, P = 0.11) and CKD 4 + 5 (OR = 4.57, 95%CI 1.81, 11.50,
P = 0.001), when compared to the normal eGFR group. Supple-
mentary Table 1 summarises the multivariable analysis of
stratiﬁed eGFR on outcomes.
Stratifying admission eGFR into the CKD classiﬁcation, mortali-
ty was again higher and worsened with decreasing eGFR when
compared to normal eGFR. The following adjusted ORs were
demonstrated in the corresponding CKD classiﬁcations; CKD 3a
(OR = 2.99, 95%CI 1.36–6.57, P = 0.006), CKD 3b (OR = 3.24,
95%CI 1.31–8.05, P = 0.11) and CKD 4 + 5 (OR = 4.57, 95%CI 1.81,
11.50, P = 0.001), when compared to the normal eGFR group.
Table 2
The base model, adjusted for age group, eGFR and albumin.
Mort 90 Mort 30 Readmission 30
OR 95% CI OR P-value OR 95% CI OR P-value OR 95% CI OR P-value
Age group
65–74
75–84 1.56 0.78–3.11 0.21 1.04 0.42–2.62 0.93 1.34 0.84–2.14 0.22
85 2.02 0.86–4.76 0.11 2.39 0.90–6.33 0.08 1.23 0.64–2.37 0.53
eGFR
<60 ml/min/1.73 m2 3.37 1.82–6.27 <0.001 2.98 1.38–6.43 0.006 1.21 0.76–1.91 0.42
Albumin
35 2.57 1.38–4.79 0.003 3.1 1.39–6.89 0.006 1.35 0.96–1.90 0.08
Table 3
The effects of the additional covariates after adjustment of the base model (age group, albumin and eGFR).
Mort 90 Mort 30 Readmission 30
OR 95% CI OR P-value OR 95% CI OR P-value OR 95% CI OR P-value
Sex 1.33 0.76–2.32 0.31 1.52 0.76–3.03 0.24 1.1 0.79–1.52 0.57
Operation 0.72 0.37–1.38 0.32 0.81 0.37–1.78 0.6 0.65 0.44–0.96 0.03
Poly pharmacy (5 drugs) 1.98 1.03–3.77 0.039 1.5 0.67–3.32 0.32 1.97 1.37–2.82 <0.001
Multimorbidity (2) 2.32 1.13–4.75 0.021 1.96 0.79–4.86 0.15 1.39 0.93–2.07 0.1
Haem (<130 g/L) 1.1 0.61–2.00 0.75 0.77 0.37–1.59 0.47 1.46 1.02–2.09 0.04
The above have been adjusted for, age groups (65–74, 75–84, above 85), albumin and eGFR (>60, <60).
Table 1
Characteristics of 402 patients comparing baseline characteristics against outcomes.
Total in cohort Mortality at 90 days Mortality at 30 days Readmission at 30 days
Dead Alive Dead Alive Yes No
Patients, n (%) 402 (100) 40 (10) 358 (89.1) 22 (5.5) 378 (94.0) 95 (23.6) 296 (73.6)
Surgery, n (%) 141 (35.1) 8 (5.7) 131 (92.9) 5 (3.5) 134 (95.0) 26 (18.4) 108 (76.6)
Sex, n (%)
Male 209 (52%) 24 (11.5) 182 (87.1) 13 (6.2) 194 (92.8) 55 (26.3) 149 (71.3)
Female 193 (48%) 16 (8.3) 176 (91.2) 9 (4.7) 184 (95.3) 40 (20.7) 153 (79.3)
Age (%)
65–74 183 (45.5) 15 (8.2) 166 (90.7) 7 (3.8) 175 (95.6) 44 (24) 136 (74.3)
75–84 150 (37.3) 16 (10.7) 132 (88.0) 8 (5.3) 141 (94.0) 36 (24) 36 (24.0)
>85 69 (17.2) 9 (13) 60 (87.0) 7 (10.1) 62 (89.9) 15 (21.7) 52 (75.4)
eGFR, n (%)
60 265 (65.9) 18 (6.8) 245 (92.5) 9 (3.4) 255 (96.2) 61 (23) 202 (76.2)
<60 137 (34.1) 22 (16.1) 113 (82.5) 13 (9.5) 123 (89.8) 34 (24.8) 100 (73.0)
CKD 3a 64 (15.9) 11 (17.2) 52 (81.3) 8 (12.5) 55 (85.9) 18 (28.1) 43 (67.2)
CKD 3b 44 (10.9) 6 (13.6) 38 (86.4) 3 (6.8) 41 (93.2) 12 (27.3) 32 (72.7)
CKD 4+5 29 (7.2) 5 (17.2) 23 (79.3) 2 (6.9) 27 (93.1) 4 (13.8) 25 (86.2)
Albumin, n (%)
35 216 (53.7) 30 (13.9) 184 (85.2) 18 (8.3) 197 (91.2) 57 (26.4) 155 (71.8)
>35 141 (35.1) 8 (5.7) 133 (94.3) 3 (2.1) 138 (97.8) 27 (19.1) 114 (80.9)
Haemoglobin, n (%)
130 185 (46) 14 (7.6) 172 (93.0) 14 (7.6) 177 (95.7) 57 (30.8) 147 (79.5)
<130 216 (53.7) 8 (3.7) 186 (86.1) 3 (1.4) 200 (92.6) 27 (12.5) 153 (70.8)
Polypharmacy, n (%)
5 Drugs 256 (63.7) 27 (10.5) 227 (88.7) 13 (5.1) 242 (94.5) 73 (28.5) 176 (68.8)
<5 Drugs 139 (34.3) 11 (8.0) 128 (92.1) 7 (5.1) 132 (95.0) 22 (15.9) 117 (84.2)
Co-morbidities, n (%)
Diabetes mellitus 74 (6.7) 5 (6.8) 69 (92.0) 1 (1.4) 74 (98.7) 18 (24.3) 55 (73.3)
CCF 12 (3) 3 (25) 9 (75) 1 (8.3) 11 (91.7) 4 (33.3) 8 (66.7)
Dementia 15 (4) 2 (13.3) 13 (86.7) 2 (13.3) 13 (86.7) 4 (26.7) 10 (66.7)
Multimorbidity (2) 244 31 (12.1) 211 (86.5) 17 (7) 226 (92.6) 65 (26.6) 171 (70.1)
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stratiﬁed eGFR on outcomes.
Preoperative hypoalbuminaemia was found to predictive of 90 day
mortality, with adjusted OR = 2.57 (95%CI 1.38–4.79, P = 0.003).
3.2. Outcome 2: mortality within 30 days
The adjusted odds ratio of death were again higher in patients
with an admission eGFR corresponding <60 ml/min/1.73 m2
(OR = 2.98, 95%CI 1.38–6.43, P = 0.006) when compared to patients
with normal renal function. Similarly, on stratiﬁcation of eGFR intothe CKD groupings, there was a trend towards an increasing odds
ratio of mortality with increasing renal impairment; this is shown
in Supplementary Table 1. However, only patients with an eGFR
corresponding to CKD 3a showed a signiﬁcant increase in mortality
(OR = 3.39, 95%CI 1.35–8.55, P = 0.01).
The adjusted odds ratio of death were again higher in patients
with an admission eGFR corresponding <60 ml/min/1.73 m2
(OR = 2.98, 95%CI 1.38–6.43, P = 0.006) when compared to patients
with normal renal function. Similarly, on stratiﬁcation of eGFR into
the CKD groupings, there was a trend towards an increasing odds
ratio of mortality with increasing renal impairment; this is shown
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corresponding to CKD 3a showed a signiﬁcant increase in mortality
(OR = 3.39, 95%CI 1.35–8.55, P = 0.01).
Hypoalbuminaemia again also signiﬁcant in predicting 30 day
mortality when compared patients with an albumin of >35 g/L
with an adjusted OR = 3.1 (95% 1.39–6.89, P = 0.006).
3.3. Outcome 3: readmission within 30 days
Multivariable analysis did not demonstrate any signiﬁcant
increase in readmission rates for patients with an admission eGFR
of <60 ml/min/1.73 m2 (OR = 1.21, 95%CI 0.76–1.91, P = 0.42)
when compared to patients with normal renal function or when
stratiﬁed by CKD grouping. Supplementary Table 1 and Table 2
illustrate these ﬁndings.
Multivariable analysis did not demonstrate any signiﬁcant
increase in readmission rates for patients with an admission eGFR
of <60 ml/min/1.73 m2 (OR = 1.21, 95%CI 0.76–1.91, P = 0.42)
when compared to patients with normal renal function or when
stratiﬁed by CKD grouping. Supplementary Table 1 and Table 2
illustrate these ﬁndings.
4. Discussion
This international multicentre study on emergency general
surgical patients aged 65 years or older demonstrated that
admission eGFR is a predictor for the clinically relevant outcomes
of 30- and 90-day mortality. Patients with an admission eGFR of
<60 ml/min were three times more likely to die at 30 days or
90 days when compared to patients with normal eGFR. Previous
studies have demonstrated impaired renal function preoperatively
is a predictor of 30 day mortality in an elective surgical setting
[8,11–13,15]. However, these studies did not investigate 90 day
mortality, nor did they speciﬁcally look at older surgical
emergency patients. No signiﬁcant relationship between admis-
sion eGFR and readmission within 30 days of discharge was
demonstrated in our study. To our knowledge, this is the ﬁrst
report of the impact of admission eGFR on outcomes in older
people in an acute surgical setting.
Although these results indicate a progressive increased trend in
the odds of death with increasing renal impairment from CKD
stage 3–5, they did not reach statistical signiﬁcance, which may be
due to fewer patients with renal function of <60 ml/min/1.73 m2, a
weakness of this paper that underpowered the study. However a
study in elective cardiac surgery demonstrated that when
compared to a preoperative eGFR corresponding to CKD 1,
progressive renal impairment up to CKD 4 increased the likelihood
of mortality within 30 days [11]. Another large study on
preoperative eGFR and surgical outcomes in an elective general
surgical population also demonstrated increased likelihood of
mortality within 30 days of admission with progressive CKD [8]. In
contrast to this report, neither of these two studies [8,11] found
impaired renal function as a predictor of 90 day mortality.
Although our study did not ﬁnd admission eGFR to be a
predictor of readmission within 30 days of discharge, one study on
patients undergoing lower limb vascular procedures found that
CKD was associated with increased odds of readmission 30 days
after discharge [16]. However, they only found this association in
those with stage 4 or 5 CKD. This discrepancy may again be due to a
lack of power.
Another ﬁnding of this study is admission hypoalbuminaemia,
deﬁned as 35 g/L, being predictive of 30 and 90 day mortality. We
were unable to ﬁnd a directly comparable study to our own
demonstrating albumin being predictive of 30 day mortality in a
general surgical population. A previous study has shownpreoperative hypoalbuminaemia to be a risk factor for death
within 90 days of surgery in patients undergoing elective radical
cystectomy for bladder cancer, which is keeping with our results
[17]. Hypoalbuminaemia has also found to be predictive of
mortality in patients undergoing elective colectomies for
colorectal cancer [18].
It is postulated that hypoalbuminaemia reﬂects not only
nutritional deﬁciencies, but a systemic inﬂammatory response
that compromises immune function prior to surgery and impairs
recovery postoperatively [19]. However, even after adjustment for
this confounding variable, eGFR still predicted mortality on our
study population.
A notable weakness of this study was the lack of data relating to
acute kidney injury (AKI), pre-existing CKD or acute-on-chronic
renal injury at admission. This lack of information is a possible
confounder, as studies in predominantly intensive care popula-
tions, have shown that patients with acute-on-chronic renal injury
have a lower mortality when compared to patients with AKI and no
background of CKD [20–22]. Though the ﬁndings in this study
show an increased risk of poor outcomes as eGFR deteriorated
when compared to normal eGFR, the risk in clinical stages of mild
and moderately decreased eGFR appeared approximately the
same. While the analysis did adjust for several common
confounding variables, such as age and albumin, it was not
possible to adjust for all potential confounding variables, for
example, nephrotoxic medications, as these data were not
collected to that degree of granularity. Also a priori analysis plan
was in place to prevent multiplicity during our analysis.
Serum creatinine based eGFR calculation may over-estimate
kidney function and this might have resulted in some severely ill
patients, with low muscle mass, being included in the 60 ml/min/
1.73 m2 category. Thus, patients creatinine based eGFR category of
60 ml/min/1.73 m2 may actually be at increased risk of poor
clinical outcomes, attenuating the relationships observed.
This study was conducted at multiple sites across the UK and a
single site in Belgium, with only minor differences in surgical
practice between them. Sites varied in their location, with urban
and rural populations and both academic and non-academic
centres. Therefore, this sample would appear to be representative
of a Northern European older emergency surgical population.
5. Conclusion
Admission eGFR provides useful prognostic information to
clinicians and their patients. Our results suggest that preoperative
eGFR should be checked in every emergency surgical admission.
Those patients with CKD stage 3–5 should be considered for High
Dependency monitoring, especially if emergency surgery is being
considered. Indeed this is a proposal supported by the recent
National Emergency laparotomy Audit (www.nela.org). Prospec-
tive research should be performed to identify all interventions on
kidney function that reduce the risk of complications and
mortality. Whether closer monitoring and focused management
at improving kidney function improves outcome in this patient
population warrants further investigation.
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